Palisade Bio, Inc.
PALI
$1.67
-$0.17-9.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.02% | -24.84% | 33.31% | 4.10% | 14.53% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -- | -100.00% | 0.00% |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 316.30% | -7.07% | -55.41% | 1,918.18% | -97.65% |
| Change in Net Operating Assets | -233.79% | 493.60% | -127.40% | 116.67% | 205.36% |
| Cash from Operations | -95.54% | 22.12% | 2.02% | 24.00% | 10.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 48.72% | -39.29% | -- |
| Issuance of Common Stock | 97,600.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -48.33% | -76.47% | 83.41% |
| Cash from Financing | 83,975.00% | 101.55% | -106.20% | 2,412.22% | -105.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.52% | 30.03% | -245.48% | 153.76% | -4,402.60% |